Proteus
Customer satisfaction is the reason for Proteos’ ongoing success and why customers continue to return with new requests. The reason is simple…meeting client specifications and timelines as well as providing ongoing project updates. We work through the Request for Quotation process to assure that we understand the specifications of your project before we begin. We clarify the specifications to assure that the protein meets your requirements. Based on this information, we begin your project within 1 week of receiving your purchase order. Most projects are milestone driven, thus keeping you in control throughout the process and allowing you to manage critical decisions and effectively manage your outsourcing budget. Proteos is committed to assuring that you know the exact status of your project, therefore you will receive any data as it is received as well as a weekly update. Lastly, we understand the importance of your timelines, so we are committed to delivery of your protein on time, meeting your specification for both purity and quantity. Customer satisfaction is our goal for every project.
Proteos Leadership Team
Clark W. Smith, Ph.D.
Co-Founder & CEO
Dr. Smith's career spans 6 years in academia and 23 years at Upjohn/Pharmacia in Kalamazoo where he was Director of Protein Sciences and leader of the peptide synthesis group. From 1998-2003, Dr. Smith was Senior Director of Global Research Site Operations. His expertise is in peptide chemistry, and he is one of the founding officers of the American Peptide Society with >85 peer-reviewed publications.
George B. Gross
President
Mr. Gross directs the sales and business development activities within Proteos. He brings 30 years of sales and marketing leadership from Upjohn/Pharmacia to the management team of Proteos.
Martin R. Deibel, Jr., Ph.D.
Head of Protein Purification
Dr. Deibel is an internationally recognized investigator in protein science. He had 19 years experience at Upjohn/Pharmacia in Kalamazoo in leading team efforts in production, purification, and assay development of key target proteins in a number of therapeutic areas. Dr. Deibel lists over 75 peer reviewed papers in protein science.
Robert L. Heinrikson, Ph.D.
Co-Founder & Chief Scientific Advisor
Dr. Heinrikson is known internationally as one of the world's leading protein chemists. His career has been equally divided between academia and the pharmaceutical industry, with 18 years as Professor of Biochemistry at the University of Chicago and 19 years as Senior Research Scientist and Distinguished Fellow at Upjohn/Pharmacia in Kalamazoo, MI. He is on the editorial board of four journals in the field of biochemistry, with 20 years service as editor of the Journal of Biological Chemistry. Dr. Heinrikson's field of expertise is protein chemistry and protein structure-function relationships; he lists >200 peer-reviewed publications, review articles and book chapters.